Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells.
Megen C WittlingHannah M KnochelmannMegan M WyattGuillermo O Rangel RiveraAnna C ColeGregory B LesinskiChrystal M PaulosPublished in: bioRxiv : the preprint server for biology (2023)
based T cell therapies are now emerging in the clinic.